Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients

Journal of Affective Disorders

Volumn 79, Issue 1-3, 2004, Pages 51-61

  Straneva Meuse, Patricia A ^a   Light, Kathleen C ^a   Allen, Michael T ^b   Golding, Michael ^a   Girdler, Susan S ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b Division of Education   (United States)

Author keywords

Bupropion; Depression; Heart rate variability; Paroxetine; Stress

Indexed keywords

ADRENALIN; AMFEBUTAMONE; HYDROCORTISONE; PAROXETINE;

ADRENALIN BLOOD LEVEL; ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HEART OUTPUT; HEART RATE VARIABILITY; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; MENTAL STRESS; NEUROENDOCRINE SYSTEM; PHYSICAL STRESS; PRIORITY JOURNAL; REST; STANDING; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASCULAR RESISTANCE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD PRESSURE; BUPROPION; CROSS-SECTIONAL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPINEPHRINE; HEART RATE; HUMANS; HYDROCORTISONE; NEUROSECRETORY SYSTEMS; PAROXETINE; STRESS, PSYCHOLOGICAL;

EID: 1542719300     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00352-X     Document Type: Article

References (38)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition (DSM-IV) :1994;American Psychiatric Association, Washington, DC.
2. Amsterdam J.D., Maislin G., Winokur A., Berwish N., Kling M., Gold P. The oCRH test before and after clinical recovery from depression. J. Affect. Disord. 14:1988;213-222.
3. Barden N., Reul J.M.H.M., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system. Trends Neurosci. 18:1995;6-11.
4. Bigger J.T., Fleiss J.L., Rolnitzky L.M., Steinman R.C. The ability of several short-term measures of RR variability to predict mortality after myocardial infarction. Circulation. 88:(3):1993;927-934.
5. Carney R.M., Freedland K.E., Veith R.C., Cryer P.E., Skala J.A., Lynch T., Jaffe A.S. Major depression, heart rate, and plasma norepinephrine in patients with coronary heart disease. Biol. Psychiatry. 45:1999;458-463.
6. Carney R.M., Freedland D.K., Stein P.K., Skala J.A., Hoffman P., Jaffe A.S. Change in heart rate and heart rate variability during treatment for depression in patients with coronary heart disease. Psychosom. Med. 62:2000;639-647.
7. Dalack G., Roose S. Perspectives on the relationship between cardiovascular disease and affective disorder. J. Clin. Psychiatry. 51:(Suppl. 7):1990;4-9.
8. Dreifus L.S., Agarwal J.B., Botvinick E.H., et al. Heart rate variability for risk stratification of life-threatening arrhythmias (Citation). J. Am. Coll. Cardiol. 22:1993;948-950.
9. Frasure-Smith N., Lesperance F., Juneau M., Talajic M., Bourassa M.G. Gender, depression and one-year prognosis after myocardial infarction. Psychosom. Med. 61:1999;26-37.
10. Freedland K.E., Carney R.M., Lustman P.J., Rich M.W., Jaffe A.S. Major depression in coronary artery disease patients with vs. without a prior history of depression. Psychosom. Med. 54:(4):1992;416-421.
11. Hance M., Carney R.M., Freedland K.E., Skala J. Depression in patients with coronary heart disease. Gen. Hosp. Psychiatry. 18:1996;61-65.
12. Horst W.D., Preskorn S.H. Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, and bupropion. J. Affect. Disord. 51:1998;237-254.
13. Hyman S.E., Nestler E.J. The Molecular Foundations of Psychiatry. 1993;American Psychiatric Press, Washington, DC.
14. Jonas B.S., Franks P., Ingram D.D. Are symptoms of anxiety and depression risk factors for hypertension? Longitudinal evidence from the National Health and Nutrition Examination Survey. I. Epidemiologic follow-up study. Arch. Fam. Med. 6:1997;43-49.
15. Jonas B.S., Mussolino M.E. Symptoms of depression as a prospective risk factor for stroke. Psychosom. Med. 62:2000;463-471.
16. Kirschbaum C., Pirke K.-M., Hellhammer D.H. The 'Trier Social Stress Test' - A tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology. 28:1993;76-81.
17. Krittayaphong R., Cascio W.E., Light K.C., Sheffield D., Golden R.N., Finkel J.B., Glekas G., Koch G.G., Sheps D.S. Heart rate variability in patients with coronary artery disease: differences in patients with higher and lower depression scores. Psychosom. Med. 59:1997;231-235.
18. Kubicek W.G., Krnegis J.N., Patterson R.P., Witsoe D.A., Mattson R.H. Development and evaluation of an impedance cardiac output system. Aerospace Med. 37:1996;1208-1212.
19. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. New Engl. J. Med. 322:1990;1561-1566.
20. Light K.C., Kothandapani R.V., Allen M.T. Enhanced cardiovascular and catecholamine responses in women with depressive symptoms. Int. J. Psychophysiol. 28:1998;157-166.
21. Michelson D., Galliven E., Hill L., Demitrack M., Chrousos G., Gold P. Chronic imipramine is associated with diminished hypothalamic-pituitary-adrenal axis responsivity in healthy humans. J. Clin. Endocrinol. Metab. 82:1997;2601-2606.
22. Moser M., Lehofer M., Hoehn-Saric R., McLeod D., Hildebrandt G., Steinbrenner B., Voica M., Liebmann P., Zapotoczky G. Increased heart rate in depressed subjects in spite of unchanged autonomic balance? J. Affect. Disord. 48:1998;115-124.
23. Musselman D.L., Evans D.L., Nemeroff C.B. The relationship of depression to cardiovascular disease. Arch. Gen. Psychiatry. 55:1998;580-592.
24. Musso N.R., Vergassola C., Pende A., Lotti G. Simultaneous measurement of plasma catecholamine (norepinephrine, epinephrine, and dopamine) and free n-methyl dopamine (epinine) levels, by HPLC with electrochemical detection. J Liquid Chromatography. 13:(11):1990;2217-2228.
25. Pratt L.A., Ford D.E., Crum R.M., Armenian J.K., Gallo J.J., Eaton W.W. Depression, psychotropic medication, and risk of myocardial infarction: prospective data from the Baltimore ECA follow-up. Circulation. 94:1996;3123-3129.
26. Rechlin T., Weis M., Spitzer A., Kaschka W.P. Are affective disorders associated with alteration of heart rate variability? J. Affect. Disord. 32:1994;271-275.
27. Roose S.P., Dalack G.W., Glassman A.H., Woodring S., Walsh T., Giardina E.G.V. Cardiovascular effects of bupropion in depressed patients with heart disease. Am. J.Psychiatry. 148:1991;512-516.
28. Roose S.P., Laghrissi-Thode F., Kennedy J.S., Nelson J.C., Bigger J.T. Jr., Pollock B.G., Gaffney A., Narayam M., Finkel M.S., McCafferty J., Gergel I. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease. J. Am. Med. Assoc. 279:1998;287-291.
29. Roy A., Guthrie S., Pickar D., Linnoila M. Plasma NE responses to cold challenge in depressed patients and normal controls. Psychiatry Res. 21:1987;161-168.
30. Saab P.C., Llabre M.M., Schneiderman N., Hurwitz B., McDonald P.G., Evans J., Wohlgemuth W., Hayaski P., Klein B. Influence of ethnicity and gender on cardiovascular responses to active coping and inhibitory-passive coping challenges. Psychosom. Med. 59:1997;434-446.
31. Sheline Y.I., Freedland K.E., Carney R.M. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease? Am. J. Med. 102:1997;54-59.
32. Sherwood A., Allen M.T., Fahrenberg J., Kelsey R.M., Lovallo W.R., van Doornen L.J.P. Committee Report: methodological guidelines for impedance cardiography. Psychophysiology. 27:1990;1-23.
33. Sherwood A., Johnson K., Blumenthal J.A., Hinderliter A.L. Endothelial function and hemodynamic responses during mental stress. Psychosom. Med. 61:1999;365-370.
34. Stahl S.M. Mechanism of action of serotonin selective reuptake inhibitors: Serotonin receptors and pathways mediate therapeutic effects and side effects. J. Affect. Disord. 51:1998;215-235.
35. Stein P.K., Carney R.M., Freedland K.E., Skala J.A., Jaffe A.S., Kleiger R.E., Rottman J.N. Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease. J. Psychosom. Res. 48:2000;493-500.
36. Veith R.C., Lewis R.N., Linares O.A., Barnes R.F., Raskind J.A., Villacres E.C., Murburg M.M., Ashleigh A., Castillo S., Peskind E.R., Pauscualy M., Halter J.B. Sympathetic nervous system activity in major depression. Arch. Gen. Psychiatry. 51:1994;411-422.
37. Wenger T.L., Stern W.C. The cardiovascular profile of bupropion. J. Clin. Psychiatry. 45:1983;176-182.
38. Young E.A., Lopez J.F., Murphy-Weinberg V., Watson S.J., Akil H. Hormonal evidence for altered responsiveness to social stress in major depression. Neuropsychopharmacology. 23:2000;411-418.